R Squared’s BioAge Labs BIOA Stock Holding History

R Squared’s Portfolio BIOA Stock Details BIOA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-15,006	Closed	-$199K	–	686
2025 Q4	$199K	Sell	15,006 -11,153	-43%	-$98.9K	0.09%	364
2025 Q3	$154K	Buy	+26,159	New	+$122K	0.07%	412

Other funds holding BIOA

ACM

AH Capital Management Menlo Park, California $1.29B AUM 26.81% 1-Year Est. Return

CAM

Cormorant Asset Management Boston, Massachusetts $1.99B AUM 737.95% 1-Year Est. Return

Sofinnova Investments Menlo Park, California $2.63B AUM 117.41% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

OCA

Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

Balyasny Asset Management Chicago, Illinois $77.1B AUM 42.89% 1-Year Est. Return

Braidwell Stamford, Connecticut $3B AUM 46.72% 1-Year Est. Return

R Squared's BIOA Position: Q1 2026 in Review

R Squared sold out of BioAge Labs (BIOA) in Q1 2026, closing a stake of 15,006 shares — an estimated $199K sold.

R Squared first reported a position in BIOA in Q3 2025 and held it in 2 quarters. The position peaked at $199K in Q4 2025. 144 funds tracked by Wall St. Rank hold BIOA as of Q1 2026.

R Squared reported no remaining BioAge Labs position as of Q1 2026 after selling out during the quarter.
R Squared sold 15,006 BioAge Labs shares in Q1 2026, an estimated $199K.
R Squared first reported a position in BioAge Labs in Q3 2025 and held it in 2 quarters.
R Squared's BioAge Labs position peaked at $199K in Q4 2025.
144 funds tracked by Wall St. Rank held BioAge Labs as of Q1 2026.

Based on R Squared's 13F filing for Q1 2026, filed 29 Apr 2026.